Bank of America’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Buy
572,295
+88,627
+18% +$446K ﹤0.01% 4037
2025
Q4
$3.27M Sell
483,668
-6,416
-1% -$45K ﹤0.01% 3695
2025
Q3
$3.42M Buy
490,084
+15,711
+3% +$109K ﹤0.01% 4364
2025
Q2
$2.9M Buy
474,373
+10,351
+2% +$68.8K ﹤0.01% 4421
2025
Q1
$3.53M Sell
464,022
-26,279
-5% -$220K ﹤0.01% 4168
2024
Q4
$4.72M Sell
490,301
-20,492
-4% -$160K ﹤0.01% 3650
2024
Q3
$3.02M Buy
510,793
+24,023
+5% +$159K ﹤0.01% 4203
2024
Q2
$3.37M Buy
486,770
+30,480
+7% +$214K ﹤0.01% 3985
2024
Q1
$3.51M Sell
456,290
-89,903
-16% -$723K ﹤0.01% 3966
2023
Q4
$4.79M Sell
546,193
-69,878
-11% -$512K ﹤0.01% 3587
2023
Q3
$4.49M Buy
616,071
+64,898
+12% +$483K ﹤0.01% 3501
2023
Q2
$3.64M Sell
551,173
-51,632
-9% -$263K ﹤0.01% 3690
2023
Q1
$2.06M Buy
602,805
+64,933
+12% +$251K ﹤0.01% 4329
2022
Q4
$1.5M Sell
537,872
-5,164
-1% -$15.4K ﹤0.01% 4515
2022
Q3
$1.56M Buy
543,036
+118,329
+28% +$421K ﹤0.01% 4501
2022
Q2
$1.47M Buy
424,707
+125,359
+42% +$491K ﹤0.01% 4564
2022
Q1
$1.41M Sell
299,348
-101,608
-25% -$497K ﹤0.01% 4910
2021
Q4
$2.42M Buy
400,956
+59,690
+17% +$415K ﹤0.01% 4364
2021
Q3
$2.07M Sell
341,266
-28,636
-8% -$323K ﹤0.01% 4409
2021
Q2
$4.63M Buy
369,902
+103,989
+39% +$1.13M ﹤0.01% 3582
2021
Q1
$2.74M Buy
265,913
+21,174
+9% +$205K ﹤0.01% 3967
2020
Q4
$2.22M Buy
+244,739
New +$1.76M ﹤0.01% 3860
2018
Q4
Sell
-168,461
Closed -$1.04M 7262
2018
Q3
$1.04M Sell
168,461
-168,041
-50% -$759K ﹤0.01% 4454
2018
Q2
$2.15M Buy
336,502
+34,843
+12% +$248K ﹤0.01% 3923
2018
Q1
$2.1M Sell
301,659
-127,552
-30% -$1.49M ﹤0.01% 3844
2017
Q4
$5.41M Buy
429,211
+28,865
+7% +$352K ﹤0.01% 3054
2017
Q3
$4.76M Buy
400,346
+121,178
+43% +$1.8M ﹤0.01% 3223
2017
Q2
$4.18M Buy
279,168
+34,481
+14% +$460K ﹤0.01% 3210
2017
Q1
$2.33M Buy
244,687
+68,475
+39% +$578K ﹤0.01% 3741
2016
Q4
$1.56M Buy
176,212
+81,663
+86% +$734K ﹤0.01% 3983
2016
Q3
$811K Buy
94,549
+1,859
+2% +$14.7K ﹤0.01% 4299
2016
Q2
$739K Buy
92,690
+5,277
+6% +$41.1K ﹤0.01% 4399
2016
Q1
$764K Buy
87,413
+11,836
+16% +$98.4K ﹤0.01% 4296
2015
Q4
$708K Buy
75,577
+5,506
+8% +$47.7K ﹤0.01% 4601
2015
Q3
$677K Sell
70,071
-104,615
-60% -$1.1M ﹤0.01% 4596
2015
Q2
$2.02M Buy
174,686
+142,034
+435% +$1.46M ﹤0.01% 3444
2015
Q1
$339K Sell
32,652
-59,390
-65% -$556K ﹤0.01% 4578
2014
Q4
$1.06M Sell
92,042
-996,242
-92% -$9.84M ﹤0.01% 3991
2014
Q3
$7.76M Sell
1,088,284
-6,329
-0.6% -$44.1K ﹤0.01% 2158
2014
Q2
$7.76M Buy
1,094,613
+15,944
+1% +$93.3K ﹤0.01% 2169
2014
Q1
$6.61M Sell
1,078,669
-328,927
-23% -$2.42M ﹤0.01% 2153
2013
Q4
$12.3M Sell
1,407,596
-91,429
-6% -$560K ﹤0.01% 1657
2013
Q3
$6.25M Sell
1,499,025
-155,667
-9% -$858K ﹤0.01% 2204
2013
Q2
$11.7M Buy
+1,654,692
New +$11.6M ﹤0.01% 1602

Other funds holding MDXG

Bank of America's MDXG Position: Q1 2026 in Review

Bank of America increased its MiMedx Group (MDXG) stake by 18% in Q1 2026, buying an estimated $446K and bringing the position to 572,295 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4037.

Bank of America first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $12.3M in Q4 2013. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Bank of America held 572,295 shares of MiMedx Group worth $2.26M as of Q1 2026.
  • Bank of America bought 88,627 MiMedx Group shares in Q1 2026, an estimated $446K.
  • MiMedx Group made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4037 holding.
  • Bank of America first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
  • Bank of America's MiMedx Group position peaked at $12.3M in Q4 2013.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.